Relugolix: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Relugolix. Educational only — not medical advice.
Labeled uses
ORGOVYX is indicated for the treatment of adult patients with advanced prostate cancer.
Source: FDA labeling via NIH DailyMed (set 077a92f6…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.